Efficacy and safety of dendrimer-enhanced (DEP) cabazitaxel (CTX-SPL9111) in advanced esophagogastric cancers in a phase 1/2 trial.
| Autor: | Pinato, David James, Jones, Robert Hugh, Forster, Martin D., Joshua, Anthony M., Korolewicz, James, Benafif, Sarah, Aboud, Karam, Liu, Jia, Cosman, Rasha, Paull, Jeremy, Fairley, Jacinth, Edmondson, Stephanie Ruth, Spicer, James F. |
|---|---|
| Zdroj: | Journal of Clinical Oncology; 2024 Supplement 3, Vol. 42, p374-374, 185p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|